BIOMAT Database Logo BIOMAT Database Logo

Inosine formation from hypoxanthine by intact erythrocytes and fibroblasts of an immunodeficient child with purine nucleoside phosphorylase deficiency. 1984

L D Fairbanks, and D R Webster, and H A Simmonds, and C F Potter, and A R Watson

UI MeSH Term Description Entries
D007042 Hypoxanthines Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism.
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D007288 Inosine A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010430 Pentosyltransferases Enzymes of the transferase class that catalyze the transfer of a pentose group from one compound to another.
D011683 Purine-Nucleoside Phosphorylase An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1. Inosine Phosphorylase,Nicotinamide Riboside Phosphorylase,Purine Nucleoside Phosphorylases,Nucleoside Phosphorylases, Purine,Phosphorylase, Inosine,Phosphorylase, Nicotinamide Riboside,Phosphorylase, Purine-Nucleoside,Phosphorylases, Purine Nucleoside,Purine Nucleoside Phosphorylase,Riboside Phosphorylase, Nicotinamide
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast

Related Publications

L D Fairbanks, and D R Webster, and H A Simmonds, and C F Potter, and A R Watson
Inosine uptake by cultured fibroblasts from normal and purine nucleoside phosphorylase-deficient humans.
June 1977, The Journal of biological chemistry,
L D Fairbanks, and D R Webster, and H A Simmonds, and C F Potter, and A R Watson
Altered purine and pyrimidine metabolism in erythrocytes with purine nucleoside phosphorylase deficiency.
April 1980, Biochemical genetics,
L D Fairbanks, and D R Webster, and H A Simmonds, and C F Potter, and A R Watson
Purine metabolism in intact cells from a purine nucleoside phosphorylase deficient child.
January 1984, Advances in experimental medicine and biology,
L D Fairbanks, and D R Webster, and H A Simmonds, and C F Potter, and A R Watson
Purine nucleoside phosphorylase from human erythrocytes.
January 1978, Methods in enzymology,
L D Fairbanks, and D R Webster, and H A Simmonds, and C F Potter, and A R Watson
Purine nucleoside phosphorylase from human erythrocytes. 3. Inhibition by the inosine analog formycin B of the isolated enzyme and of nucleoside metabolism in intact erythrocytes and sarcoma 180 cells.
May 1968, Molecular pharmacology,
L D Fairbanks, and D R Webster, and H A Simmonds, and C F Potter, and A R Watson
[Purine nucleoside phosphorylase deficiency].
January 2000, Ryoikibetsu shokogun shirizu,
L D Fairbanks, and D R Webster, and H A Simmonds, and C F Potter, and A R Watson
Purine nucleoside phosphorylase deficiency.
January 1991, Immunodeficiency reviews,
L D Fairbanks, and D R Webster, and H A Simmonds, and C F Potter, and A R Watson
Deficiency of purine nucleoside phosphorylase activity in thymocytes from the immunodeficient diabetic BB rat.
November 1991, Clinical and experimental immunology,
L D Fairbanks, and D R Webster, and H A Simmonds, and C F Potter, and A R Watson
Purine nucleoside phosphorylase. Inosine hydrolysis, tight binding of the hypoxanthine intermediate, and third-the-sites reactivity.
July 1992, Biochemistry,
L D Fairbanks, and D R Webster, and H A Simmonds, and C F Potter, and A R Watson
Inhibition of human purine nucleoside phosphorylase. Studies with intact erythrocytes and the purified enzyme.
June 1968, The Journal of biological chemistry,
Copied contents to your clipboard!